Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.)
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.)
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aprepitant to Improve Same Day Discharge for TKA | Nausea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Nausea and Vomiting, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Not yet recruiting | Phase 4 | 2026-06-10 | NCT07639723 |